Abstract

BackgroundColon cancer is a heterogeneous tumor and a leading cause of cancer-related mortality. MicroRNA (miRNA) has been proposed as the biomarker in cancers. The aim of this study was to investigate the clinical significance and potential functional role of miR-937 in colon cancer.MethodsIn the present study, reverse transcription-quantitative polymerase chain reaction (qRT-PCR) was conducted to examine the expression levels of miR-937 in colon cancer tissues and cell lines. Kaplan-Meier curve and Cox regression analyses were used to determine the prognostic impact of miR-937 on survival. Cell Counting Kit-8 and Transwell assays were performed to examine cell proliferation, migration, and invasion, respectively.ResultsmiR-937 was significantly upregulated in colon cancer tissues and cell lines. Clinical analysis results showed that miR-937 expression was associated with lymph node metastasis and TNM stage. Patients with high miR-937 expression predicted a shorter overall survival rate. Functionally, overexpression of miR-937 promoted cell proliferation, migration, and invasion, while inhibition of miR-937 inhibited these cellular behaviors in vitro.ConclusionsThese results suggested that miR-937 may act as a prognostic biomarker and a potential target for therapeutic strategy, as well as promote proliferation, migration, and invasion of colon cancer.

Highlights

  • Colon cancer is one of the most common malignant tumors of the digestive tract and the leading cause of cancer-related mortality worldwide [1, 2]

  • Results miR-937 expression levels in colon cancer patients and cell lines The expression levels of miR-937 in tumor and adjacent normal tissue specimens of 109 colon cancer patients were detected by the reverse transcriptionquantitative polymerase chain reaction (qRT-PCR) assay

  • The expression levels of miR-937 were determined in colon cancer cell lines (LoVo, SW620, CW-2, HCT116) and a normal colonic epithelial cell line NCM460

Read more

Summary

Introduction

Colon cancer is one of the most common malignant tumors of the digestive tract and the leading cause of cancer-related mortality worldwide [1, 2]. Colon cancer patients at early stages often have longterm survival, colon cancer with early-onset symptoms is not typical and the patients usually initially diagnosed at advanced stages with unsatisfactory prognosis [4]. Better cancer-related biomarkers and Numerous studies have demonstrated that abnormal expression of microRNAs (miRNAs) is closely linked to the initiation and development of cancers [6]. MiRNAs, including miR-378 [11], miR-590-3p [12], and miR-34b [13], are abnormally expressed and function as oncogenic or suppressor role in colon cancer. Colon cancer is a heterogeneous tumor and a leading cause of cancer-related mortality. The aim of this study was to investigate the clinical significance and potential functional role of miR-937 in colon cancer

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.